Skip to main content

Levetiracetam

NDC 44567-503 · WG Critical Care, LLC

Generic nameLevetiracetam
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)LEVETIRACETAM
Strength15 mg/mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryNDA

Packages

44567-503-10 — 10 BAG in 1 CARTON (44567-503-10) / 100 mL in 1 BAG (44567-503-01)

Billed under HCPCS

J1958 — Injection, levetiracetam in sodium chloride, 5 mg Medicare Part B payment limit (ASP + 6%): $0.03

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

43547-882 — Levetiracetam, 43547-883 — Levetiracetam, 43598-635 — Levetiracetam Injection, 43598-636 — Levetiracetam Injection, 43598-637 — Levetiracetam Injection, 43598-755 — Levetiracetam Injection, 43598-757 — Levetiracetam Injection, 43598-759 — Levetiracetam Injection, 44567-501 — Levetiracetam, 44567-502 — Levetiracetam, 48433-052 — levetiracetam, 50090-1333 — Levetiracetam, 50090-2875 — Levetiracetam, 50090-6086 — Levetiracetam, 50090-6378 — Levetiracetam, 50090-7333 — Levetiracetam, 50090-7521 — Levetiracetam, 50090-7717 — Levetiracetam, 50090-7768 — Levetiracetam, 50090-7770 — Levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources